Min Li, Ying Xue, Yuhan Chang, Fan Xu, Feizhen Wu, Xinjian Tian, Jie Hu, Yijun Song, Xufen Yu, Fei Zhou, Caicun Zhou, Xin Cao, Mei Wang, Qihong Huang. "ELMO2 is a therapeutic vulnerability in mesenchymal-like and drug-resistant non-small cell lung cancer." Nature Communications, 2026. doi:10.1038/s41467-026-72062-y